Node-Sparing Modified Short-Course Radiotherapy Combined with CAPOX and Tislelizumab for Locally Advanced MSS of Middle and Low Rectal Cancer (mRCAT): An open-label, single-arm, prospective, multicentre clinical trial
Research Square (Research Square)